143328-19-2

Basic information

• Product Name: 1-(4-bromophenyl)cyclopentanecarbonitrile(SALTDATA: FREE)
• Synonyms: 1-(4-bromophenyl)cyclopentanecarbonitrile(SALTDATA: FREE);1-(4-Bromophenyl)cyclopentanecarbonitrile;4-(1-Cyanocyclopentyl)bromobenzene;CYCLOPENTANECARBONITRILE, 1-(4-BROMOPHENYL)-;1-(4-bromophenyl)cyclopentanecarbonitrile(SALTDATA
• CAS NO: 143328-19-2
• Molecular Formula: C₁₂H₁₂BrN
• Molecular Weight: 250.13
• Mol File: 143328-19-2.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 351.3°C at 760 mmHg
• Flash Point: 166.3°C
• Appearance: /
• Density: 1.41g/cm³
• Vapor Pressure: 4.14E-05mmHg at 25°C
• Refractive Index: 1.594
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-(4-bromophenyl)cyclopentanecarbonitrile(SALTDATA: FREE)(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-bromophenyl)cyclopentanecarbonitrile(SALTDATA: FREE)(143328-19-2)
• EPA Substance Registry System: 1-(4-bromophenyl)cyclopentanecarbonitrile(SALTDATA: FREE)(143328-19-2)

Safety Data

• Hazardous Substances Data: 143328-19-2(Hazardous Substances Data)

Usage

General Description

1-(4-bromophenyl)cyclopentanecarbonitrile is a chemical compound with the formula C13H10BrN. It is a crystalline solid that is commonly used as an intermediate in the synthesis of various pharmaceuticals and organic compounds. This chemical possesses a five-membered cyclopentane ring with a cyano group and a bromophenyl group attached to it. It is also known as SALTDATA: FREE and is often used as a building block in the production of advanced materials and compounds for research and development purposes.

InChI:InChI=1/C12H12BrN/c13-11-5-3-10(4-6-11)12(9-14)7-1-2-8-12/h3-6H,1-2,7-8H2

Upstream product

• 110-52-1 1,4-dibromo-butane 
• 16532-79-9 4-Bromophenylacetonitrile 

Downstream Products

• 1616924-22-1 2-[1-(4-bromophenyl)cyclopentyl]acetamidine hydrochloride 
• 1616924-23-2 5-benzyloxy-2-[1-(4-bromophenyl)cyclopentylmethyl]-6-hydroxypyrimidine-4-carboxylic acid tert-butyl ester 
• 1616924-24-3 5-benzyloxy-2-[[1-(4-bromophenyl)cyclopentyl]methyl]-6-hydroxypyrimidine-4-carboxylic acid 
• 1616924-25-4 5-benzyloxy-2-[1-(4-bromophenyl)cyclopentylmethyl]-6-hydroxypyrimidine-4-carboxylic acid [2-(tert-butyldimethylsilanyloxy)ethyl]isopropylamide 
• 1616924-26-5 5-benzyloxy-2-[1-(4-bromophenyl)cyclopentylmethyl]-6-hydroxypyrimidine-4-carboxylic acid (2-hydroxyethyl)isopropylamide 
• 1616924-27-6 9-benzyloxy-6-[1-(4-bromophenyl)cyclopentylmethyl]-2-isopropyl-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,8-dione 
• 1616922-09-8 4-[1-(9-hydroxy-2-isopropyl-1,8-dioxo-1,3,4,8-tetrahydro-2H-pyrazino[1,2-c]pyrimidin-6-ylmethyl)cyclopentyl]benzonitrile 
• 1616924-21-0 2-[1-(4-bromophenyl)cyclopentyl]acetonitrile 
• 1616924-20-9 methanesulfonic acid 1-(4-bromophenyl)cyclopentylmethyl ester 
• 1346689-83-5 [1-(4-bromophenyl)cyclopentyl]methanol 
• 1267113-92-7 1-(4-bromophenyl)cyclopentane-1-carbaldehyde 
• 1419174-73-4 C₂₁H₂₃N 
• 1419174-60-9 1-(4'-isopropyl-[1,1'-biphenyl]-4-yl)cyclopentanecarboxylic acid 
• 1419174-47-2 C₂₁H₂₂O₂ 

Relevant articles and documents

Amide compound and derivative thereof, preparation method, pharmaceutical composition and application thereof

The invention discloses an amide compound and derivative thereof, a preparation method, a pharmaceutical composition and application thereof. The structure of the amide compound is shown as a formula (I). The derivatives of theamide compound relate to a stereoisomer, a tautomer, a metabolite, a metabolic precursor, a prodrug, a solvate, a salt of the solvate, a crystal, a pharmaceutically acceptable salt or a mixture of the above of theamide compound. The amide compound and the derivative thereof have an efficient inhibition effect on indoleamine 2, 3-dioxygenase 1, and can be used for preparing medicines for treating indoleamine 2, 3-dioxygenase 1 mediated immunosuppression related diseases, the prepared medicine can exert the medicine effect at the molecular level and is wide in application, and the synthesis method of the compound is simple, convenient and easy to operate.

Bioinspired Metal-Free Formal Decarbonylation of α-Branched Aliphatic Aldehydes at Ambient Temperature

A sequence of a Baeyer–Villiger oxidation and a Lewis acid-promoted reduction of the resulting formate with Et3SiH enabled the metal-free formal decarbonylation of tertiary and secondary aliphatic aldehydes. The new methodology mimics the biosynthetic decarbonylation pathway through oxidative C?C bond cleavage rather than the C(O)?H bond activation known from conventional Tsuji–Wilkinson-type reactions. The substrate scope is complementary to existing transition-metal-catalyzed protocols.

Direct lactonization of 2-arylacetic acids through Pd(II)-catalyzed C-H activation/C-O formation

Palladium-catalyzed direct lactonization of 2-arylacetic acids through a reaction sequence that includes C-H activation/C-O formation is reported. This method provides a concise and efficient pathway to synthesize fully functionalized benzofuranone derivatives, which are highly relevant to bioactive natural and synthetic products.